Literature DB >> 6974070

In vitro synthesis of IgG by peripheral blood lymphocytes in chronic liver disease.

M G Mutchnick, H M Lederman, A Missirian, A G Johnson.   

Abstract

In vitro IgG synthesis by peripheral blood mononuclear cells (PBM) from patients with chronic liver disease (CLD) was studied. In addition, the effect of pokeweed mitogen (PWM), polyadenylic-polyuridylic acid complexes (poly A:U) and thymosin fraction 5 on IgG synthesis was determined. Unstimulated cultures of PBM from patients with chronic active hepatitis (CAH) and alcoholic cirrhosis (AC) synthesized significantly higher quantities of IgG than the controls. Moreover, there was a direct correlation between serum IgG concentrations and the quantity of newly synthesized IgG in these unstimulated cultures. PWM, poly A:U and thymosin each stimulated increased IgG synthesis in the controls. While neither poly A:U nor thymosin enhanced IgG synthesis in patients with CLD, PWM increased IgG synthesis in CAH but not AC. These results indicate that spontaneous in vitro B cell synthesis of IgG is enhanced in CLD and may reflect antigenic stimulation in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6974070      PMCID: PMC1537271     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Relation of splenic and lymph node changes to hypergammaglobulinemia in cirrhosis.

Authors:  S GLAGOV; G KENT; H POPPER
Journal:  AMA Arch Pathol       Date:  1959-01

2.  Primary in vitro antibody response of human peripheral blood lymphocytes: role of phagocytic mononuclear cells.

Authors:  J F Delfraissy; P Galanaud; J Dormont; C Wallon
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

3.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

6.  [The diagnostic significance of immunoglobulin determination in chronic liver diseases. III. observations of progress (author's transl)].

Authors:  H Ortmans; E Wildhirt; U Welcke
Journal:  MMW Munch Med Wochenschr       Date:  1976-01-23

7.  Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.

Authors:  E W Gelfand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  Letter: T cells, B cells, and HL-A8 in chronic active hepatitis.

Authors:  P Tolentino; A Astaldi
Journal:  Lancet       Date:  1975-03-22       Impact factor: 79.321

9.  IgM turnover in chronic liver disease.

Authors:  K B Jensen; S Jarnum; L Ranek; H Westergaard
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

10.  Liver disease--a prominent cause of serum IgE elevation.

Authors:  E Van Epps; G Husby; R C Williams; R G Strickland
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

View more
  7 in total

1.  Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease.

Authors:  M A Rodriguez; J D Montano; R C Williams
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

2.  Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).

Authors:  S Tomino; H Fujiwara; T Kagimoto; H Mitsuya; H Nishimura; S Kishimoto
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

3.  Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction.

Authors:  P A Drew; P M Clifton; J T LaBrooy; D J Shearman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

4.  Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.

Authors:  G M Dusheiko; J H Hoofnagle; W G Cooksley; S P James; E A Jones
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Demonstration of non-specific B-cell stimulation in patients with cirrhosis.

Authors:  G Holdstock; W B Ershler; E L Krawitt
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

6.  Hyperglobulinaemia in chronic liver disease: relationships between in vitro immunoglobulin synthesis, short lived suppressor cell activity and serum immunoglobulin levels.

Authors:  P B Rong; J Kalsi; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Thymosin: an immunomodulator of antibody production in man.

Authors:  A Górski; G Korczak-Kowalska; M Nowaczyk; Z Gaciong; E Skopińska-Rózewska
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.